| Document |
Document Title |
|
WO/2019/170578A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
|
WO/2019/171278A1 |
The present invention is directed to heterocycloalkenyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the GPR120 and / or GPR40 receptors. 5 More particul...
|
|
WO/2019/172652A1 |
The present invention provides a novel compound and an organic light emitting device using same.
|
|
WO/2019/173602A1 |
Disclosed are halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of viral infections. Such viral infections can i...
|
|
WO/2019/170572A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
|
WO/2019/172460A2 |
Provided is a tetracarboxylic dianhydride which is a compound represented by general formula (1) [compound 1] (in formula (1), A represents one aromatic group selected from the group consisting of divalent aromatic groups which may have ...
|
|
WO/2019/171277A1 |
The present invention is directed to cycloalkenyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the GPR120 and / or GPR40 receptors. 5 More particularly, ...
|
|
WO/2019/170204A1 |
The present invention relates to a method for the manufacture of stable FDCA precursors from saccharide derived starting materials. More specific the invention relates to the synthesis of FDCA precursors such as alkyl 5-(hydroxymethyl)fu...
|
|
WO/2019/166619A1 |
The present invention relates to sulfonylureas and sulfonylthioureas of formula (I) comprising a 5-membered heteroaryl ring attached to the sulfonyl group, wherein the heteroaryl ring is di-substituted at the 3- and 4- positions relative...
|
|
WO/2019/166270A1 |
The invention relates to an organic electronic device comprising at least one electron transport, electron injection or electron generation layer comprising a compound of Formula (I) wherein all positions which are not linked to a -(A)a-...
|
|
WO/2019/168378A1 |
The present specification relates to a heterocyclic compound of formula 1 and an organic light emitting device comprising same.
|
|
WO/2019/168135A1 |
The present invention relates to a method for converting an N,N-dialkylamide compound into an ester compound using, as a catalyst, a complex of a fourth-period transition metal, the complex being obtained by reacting a precursor includin...
|
|
WO/2019/166269A1 |
The present invention relates to an organic electronic device comprising, between an anode and a cathode, at least one layer selected from an electron injection layer, an electron transport layer or an electron generation layer, the laye...
|
|
WO/2019/165576A1 |
Provided are methods for treating a subject having or at risk of developing cancer by administering a compound that preserves p53. Also disclosed are methods for protecting renewable tissues by administering a compound that stabilizes EZH2.
|
|
WO/2019/166003A1 |
The present invention belongs to the technical field of medicine, and discloses use of 14-deoxy-11,12-dehydro-8,12-epoxy-andrographolide and derivatives thereof and 14-deoxy-11,12-dehydro-7,8-ene andrographolide and 15-substituted deriva...
|
|
WO/2019/168140A1 |
Provided are an amide compound represented by general formula [I] or a salt thereof, an agricultural and horticultural microbicide containing the amide compound or a salt thereof as an active ingredient, and a method of using the agricul...
|
|
WO/2019/168866A1 |
Substituted cyclohexyl chemical entities of Formula (I): wherein Ra, G, and Rb have any of the values described herein, and compositions comprising such chemical entities; methods of making them; and their use in a wide range of methods,...
|
|
WO/2019/163826A1 |
This compound is represented by formula (1) (X1 represents O or S; and at least two of Y1, Y2 and Y3 are N, except the case where ―Ar1―Ar2 and/or ―Ar3―Ar4 is a p-terphenyl-3-yl group.).
|
|
WO/2019/159596A1 |
Provided is a method for preparing a coupled body represented by general formula (3), the coupled body being obtained by reacting a compound represented by general formula (1) and a compound represented by general formula (2) in the pres...
|
|
WO/2019/161345A1 |
Compounds are described with the general formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, and n are defined as anywhere herein, which are useful for the treatment of cancer and other dysproliferative diseases.
|
|
WO/2019/157561A1 |
Disclosed herein are methods and apparatuses for producing levoglucosenone and a substituted furan from lignocellulosic biomass. In one form, the method includes: converting lignocellulosic biomass, in contact with an acid within a multi...
|
|
WO/2019/160150A1 |
This novel valerolactone-based compound is represented by formula (I). [In the formula, X represents an allyl group, an aryl group, an ethynyl group, or a butenyl group. Y represents a single bond or a hydroxymethylene group, and Z repre...
|
|
WO/2019/160315A1 |
The present invention relates to a heterocyclic compound of formula 1 and an organic light emitting device comprising the same.
|
|
WO/2019/153954A1 |
Disclosed are a multi-substituted benzene compound having biological activity, a preparation method therefor, and an application thereof. The compound of the present invention has good biological activity and the activity of inhibiting t...
|
|
WO/2019/156510A1 |
The present invention relates to a novel synthesis method of DHPV and, more specifically, to a novel synthesis method of 5-3',4'-dihydroxyphenyl)-γ-valerolactone (DHPV) which is a major metabolite of cacao. The method has advantages in ...
|
|
WO/2019/154412A1 |
Provided are a new antimicrobial agent compound as shown in the following general formula (I), a pharmaceutically acceptable salt thereof, an ester thereof, a prodrug thereof, a solvate thereof, a deuterated compound thereof, or a stereo...
|
|
WO/2019/155127A1 |
According to an example aspect of the present invention, there is provided a method for separating and purifying furan carboxylates from a crude reaction mixture comprising furans, by utilizing high vacuum distillation in a total heating...
|
|
WO/2019/153387A1 |
Provided are an oxovanadium phosphate catalyst, and a preparation method and an application therefor. The method comprises: 1) mixing and reacting a vanadium source, a choline chloride-organic carboxylic acid eutectic solvent, and alcoho...
|
|
WO/2019/149843A1 |
A process, which process includes the following steps: a) converting a solid material containing hemicellulose, cellulose and lignin, by: (i) hydrolyzing, at a temperature equal to or less than 40 °C, preferably equal to or less than 30...
|
|
WO/2019/151419A1 |
Provided are: a polycarbonyl compound, and a derivative of said polycarbonyl compound. The polycarbonyl compound includes a chemical structure represented by formula (1n). Also provided are: a furan compound including a chemical structur...
|
|
WO/2019/149853A1 |
A process for the conversion of a solid lignocellulosic material containing hemicellulose, cellulose and lignin, the process including the following steps: (a) hydrolyzing, at a temperature equal to or less than 40 °C, preferably equal ...
|
|
WO/2019/148244A1 |
The present invention relates to new pharmaceutical agents, and to their use in the treatment of proliferative diseases, such as cancer (in particular, brain cancer).
|
|
WO/2019/144503A1 |
Disclosed are a gibberellic acid isocompound and the use thereof, belonging to the field of quality control of beer. High performance liquid chromatography, preparative chromatography, mass spectroscopy and nuclear magnetic resonance spe...
|
|
WO/2019/146781A1 |
The present invention provides an organic EL element that has high external quantum efficiency and a long service life and a compound which enables the achievement of this organic EL element; and the present invention uses a compound whi...
|
|
WO/2019/144668A1 |
Provided is a use of a porous zirconium hexametaphosphate catalyst, belonging to the field of heterogeneous catalysis. In the present invention, furfural is reduced to furfuryl alcohol with high selectivity by means of Meerwein-Pondorf-V...
|
|
WO/2019/143112A1 |
The present invention may provide an organic electroluminescent device in which a novel compound is used as a host material for a light-emitting layer, and thus the organic electroluminescent device has improved properties such as high l...
|
|
WO/2019/142135A1 |
The present invention relates to a process for preparing tc-DNA nucleoside precursors, the resulting tc-DNA nucleosides, and oligonucleotides comprising such tc-DNA nucleosides. In an embodiment of the invention, the process includes use...
|
|
WO/2019/144009A1 |
Provided herein are semisynthetic aurones, pharmaceutical compositions, and methods of treating cancer. The semisynthetic aurone compound including a structure according to Formula (I) or pharmaceutically acceptable salt thereof, where R...
|
|
WO/2019/143110A1 |
The present invention relates to a novel organic compound and an organic electroluminescent element using same and, more specifically, to a novel compound having excellent luminous performance and to an organic electroluminescent element...
|
|
WO/2019/143109A1 |
The present invention relates to a novel organic compound and an organic electroluminescent element using same and, more specifically, to a novel compound having excellent luminous performance and to an organic electroluminescent element...
|
|
WO/2019/143650A1 |
A 3-phenyl-3H-1-benzofuran-2-one compound is substituted with one or more acyloxy groups comprising 26 or more carbon atoms. A compound comprises two or more 3-phenyl-3H-1-benzofuran-2-one moieties and a second moiety selected from the g...
|
|
WO/2019/143111A1 |
The present invention relates to a novel organic compound and an organic electroluminescent element using same and, more specifically, to a novel compound having excellent thermal stability and luminous performance and to an organic elec...
|
|
WO/2019/143108A1 |
The present invention may provide an organic electroluminescent device in which at least one type of host material having electron properties, and at least one type of host material having hole properties are combined and used as a light...
|
|
WO/2019/143057A1 |
The present invention provides an acridine derivative represented by chemical formula (1) and an organic light-emitting diode comprising same.
|
|
WO/2019/139233A1 |
The present invention provides a novel heterocyclic compound and an organic light emitting element using the same.
|
|
WO/2019/137810A1 |
The invention relates to a process for synthesizing 5-hydroxymethylfurfural from a fructose-containing feedstock in the presence of at least one aprotic polar solvent and at least one dehydration catalyst, in which process the maximum in...
|
|
WO/2019/137484A1 |
A compound as a CXCR2 antagonist and an application thereof in preparing a drug as a CXCR2 antagonist. In particular, the present invention relates to a compound represented by formula (II) or an isomer or pharmaceutically acceptable sal...
|
|
WO/2019/136145A1 |
The invention provides methods utilizing Prins reaction in the preparation of compounds that may be useful as intermediates in the synthesis of halichondrin macrolides and analogs thereof. The invention also provides compounds that may b...
|
|
WO/2019/128849A1 |
The present invention relates to an organic compound and application thereof in an organic electronic device, especially organic electroluminescent diodes. The present invention further relates to an organic electronic device comprising ...
|
|
WO/2019/132148A1 |
In the present invention, lobaric acid and four analogs thereof, which are five phenolic lichen metabolites isolated from an extract of the Antarctic lichen Stereocaulon alpinum and selectively inhibit PTP1B, can be synthesized simply, e...
|
